Pediatrics International最新文献_第3页

Efficacy of parent-child interaction therapy for children born premature. 亲子互动疗法对早产儿的疗效。

IF 1.4 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15742

Miyuki Matano, Koyuru Kurane, Kei Wakabayashi, Yukari Yada, Yumi Kono, Toshihiro Tajima, Hitoshi Osaka, Yukifumi Monden

{"title":"Efficacy of parent-child interaction therapy for children born premature.","authors":"Miyuki Matano, Koyuru Kurane, Kei Wakabayashi, Yukari Yada, Yumi Kono, Toshihiro Tajima, Hitoshi Osaka, Yukifumi Monden","doi":"10.1111/ped.15742","DOIUrl":"10.1111/ped.15742","url":null,"abstract":"Background: Premature children are known to be at a high risk of developing behavioral problems. This study examined the effectiveness of parent-child interaction therapy (PCIT) in reducing behavioral problems in young children born premature.Methods: The study included 18 child-parent pairs with children born at less than 35 weeks of gestation (range: 23-34 weeks, median: 31.0 weeks) and aged 27-52 months (median: 38.0 months). They were assigned to either the PCIT group (n = 7) or the non-PCIT group (n = 11) based on maternal desire for treatment. The study was designed to examine the effects of PCIT. Specifically, the Eyberg Child Behavior Inventory (ECBI) intensity score, ECBI problem score, and Parenting Stress Index Short Form (PSI-SF) scores were compared before treatment and after 6 months.Results: In the PCIT group, the mean ECBI intensity score was 135.7 (SD = 13.5; T-score = 64) at baseline and 90.1 (SD = 15.5; T-score = 46) at post-assessment, the mean ECBI problem score was 9.8 (SD = 1.9; T-score = 54) at baseline and 4.4 (SD = 3.1; T-score = 44) at post-assessment, the mean PSI-SF total score was 60.1 (SD = 4.8; 95%tile) at baseline and 49.6 (SD = 5.6; 85%tile) at post-assessment, showing a significant improvement (ECBI intensity scores: p < 0.001, d = 2.03; ECBI problem scores: p < 0.001, d = 1.94; PSI-SF total scores: p = 0.004, d = 0.86). On the other hand, none of the scores showed significant change in the non-PCIT group.Conclusions: The PCIT can be considered as a potential treatment option for behavioral problems in young children born premature.","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139973092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Drastic fall of growth differentiation factor 15 in influenza encephalopathy. 流感脑病中生长分化因子 15 的急剧下降

IF 1.4 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15768

Daisuke Sawada, Katsunori Fujii, Tadashi Shiohama, Chihiro Saito, Shoko Yoshii, Hiromichi Hamada, Yasutoshi Koga

引用次数: 0

Obturator internus muscle abscess in a case of X-linked agammaglobulinemia. 一例 X 连锁丙种球蛋白血症患者的腹内肌脓肿。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15775

Yusuke Shimaoka, Takashi Ishikawa, Rinshu Shimabukuro, Mitsuru Kubota, Akira Ishiguro, Toshinao Kawai

引用次数: 0

Rubinstein-Taybi syndrome with ileocecal volvulus: A case report. 鲁宾斯坦-泰比综合征伴回盲肠下卷：病例报告

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15762

Takato Aikoh, Satoshi Kanada, Naoki Yokota, Naoki Hashizume, Kenichi Watanabe, Hirofumi Tsuru

引用次数: 0

Pediatric idiopathic nephrotic syndrome during COVID-19 omicron variant pandemic. COVID-19 omicron变体大流行期间的小儿特发性肾病综合征。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15779

Yoshitaka Watanabe, Yuta Onuki, Tsuneki Watanabe, Takahiro Ono, Chisato Oyake, Hirokazu Ikeda

引用次数: 0

ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. ROTEM 可用于狼疮抗凝物低凝血酶原血症综合征。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15773

Koyo Yamada, Yuto Nakajima, Kenichi Ogiwara, Toshiyuki Sakai, Kazuyoshi Fukuda, Keiji Nogami

{"title":"ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome.","authors":"Koyo Yamada, Yuto Nakajima, Kenichi Ogiwara, Toshiyuki Sakai, Kazuyoshi Fukuda, Keiji Nogami","doi":"10.1111/ped.15773","DOIUrl":"10.1111/ped.15773","url":null,"abstract":"Background: Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare disease caused by acquired factor II (FII) deficiency and lupus anticoagulant. Patients with LAHPS typically present with thrombosis and bleeding. However, little information is available on the evaluation of coagulation potential in patients with LAHPS. We examined global coagulation potentials in patients with LAHPS during the clinical course in this study.Methods: Coagulation potentials in two pediatric patients with LAHPS were assessed by measuring clotting time (CT) and clot formation time using Ca2+-triggered rotational thromboelastometry (ROTEM), CT and maximum coagulation velocity using clot waveform analysis (CWA), and lag time and peak thrombin using the thrombin generation assay (TGA). The day of admission was defined as day 0.Results: In case 1, the bleeding symptoms disappeared by day 5. However, the TGA and CWA results were markedly lower than normal, although FII activity (FII:C) returned to within the normal range by day 14. In contrast, ROTEM revealed a recovery to near-normal levels (day 14). All coagulation parameters (day 80) were within normal ranges. In case 2, coagulation potential was severely depressed until day 12, although FII:C returned to normal levels. Bleeding symptoms disappeared on day 19, and the ROTEM data revealed that the parameters were close to the normal range. The coagulation parameters in all assays were normalized on day 75.Conclusions: Recovery of coagulation potential in patients with LAHPS was slower than the recovery of FII:C. Moreover, ROTEM appeared to be clinically useful for assessing coagulation potential in patients with LAHPS.","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141306587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Two cases of pediatric splenic torsion as a possible late complication of laparoscopic fundoplication. 两例可能是腹腔镜胃底折叠术晚期并发症的小儿脾扭转。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15810

Takayuki Hiraba, Hiroya Ogita, Takayuki Yokota, Sonoko Kondo, Aya Tanaka, Ryuichi Shimono, Takashi Kusaka

引用次数: 0

Safe extraction technique of a metallic blade after heated tobacco ingestion. 加热烟草后金属刀片的安全提取技术。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15763

Keiichi Uchida, Honoka Yokoyama, Akira Yamamoto, Kiyoshi Hashimoto, Yuhki Koike, Yasuhiko Mohri

引用次数: 0

Pediatric hereditary angioedema attack triggered by COVID-19: A case report. 由 COVID-19 引发的小儿遗传性血管性水肿发作：病例报告

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15752

Jintaro Ishikawa, Eisuke Inage, Yuko Tanaka, Asuka Honjo, Takahiro Kudo, Yoshikazu Ohtsuka, Toshiaki Shimizu

引用次数: 0

Post-hoc safety/efficacy analyses from pediatric delgocitinib atopic dermatitis trials. 儿科德尔戈西尼特应性皮炎试验的事后安全性/有效性分析。

IF 1 4区医学

Pediatrics International Pub Date : 2024-01-01 DOI: 10.1111/ped.15798

Tatsuki Fukuie, Hiroyuki Toyama, Mai Tanaka, Katsuyo Ohashi-Doi, Kenji Kabashima

{"title":"Post-hoc safety/efficacy analyses from pediatric delgocitinib atopic dermatitis trials.","authors":"Tatsuki Fukuie, Hiroyuki Toyama, Mai Tanaka, Katsuyo Ohashi-Doi, Kenji Kabashima","doi":"10.1111/ped.15798","DOIUrl":"https://doi.org/10.1111/ped.15798","url":null,"abstract":"Background: Delgocitinib ointment is usually recommended for use in children at a concentration of 0.25%. However, there are no clear criteria for dosing, except that a 0.5% formulation may also be used, depending on symptom severity. Treatment of atopic dermatitis is based on combinations of topical corticosteroids, tacrolimus ointment, and delgocitinib ointment, but there are no reports on the safety of delgocitinib ointment when used in combination with other drugs.Methods: This is a post-hoc analysis of data from two delgocitinib ointment trials with pediatric atopic dermatitis patients. The efficacy and safety of the 0.25% and 0.5% formulations were compared. Efficacy and safety were evaluated after up to 4 and 56 weeks of treatment, respectively. The safety of delgocitinib ointment when used in combination with topical corticosteroids and/or tacrolimus ointment was investigated.Results: The dose-response relationship was examined according to baseline disease severity. The proportions of subjects with mild disease who achieved cumulative investigator's global assessment of 0 (clear) or 1 (almost clear) were 46.2% (0.25% ointment), 71.4% (0.5% ointment), and 7.7% (vehicle). For subjects with moderate to severe disease, the corresponding proportions were 19.0%, 20.0%, and 0.0%, respectively. No overall differences were seen in the safety profiles of the 0.25% and 0.5% delgocitinib ointment doses, or in the safety profiles of the two doses relating to disease severity or to concomitant use of topical corticosteroids and/or tacrolimus ointment.Conclusions: These analyses indicate that after up to 4 weeks of treatment, delgocitinib 0.5% ointment may be more effective than the 0.25% dose for mild atopic dermatitis, and that after up to 56 weeks of treatment, delgocitinib is well tolerated in a pediatric trial population when used as prescribed in combination with topical corticosteroids and/or tacrolimus ointment.","PeriodicalId":20039,"journal":{"name":"Pediatrics International","volume":null,"pages":null},"PeriodicalIF":1.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0